Efficacy and safety of ruxolitinib plus extracorporeal photopheresis in acute and chronic graft versus host disease: A single center experience. Ann Med Res [Internet]. 2021 Nov. 24 [cited 2025 May 9];28(11):2065-70. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/3977